These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12527106)

  • 1. Genetic regulation of cell function in response to iron overload or chelation.
    Templeton DM; Liu Y
    Biochim Biophys Acta; 2003 Jan; 1619(2):113-24. PubMed ID: 12527106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation.
    Bianchi L; Tacchini L; Cairo G
    Nucleic Acids Res; 1999 Nov; 27(21):4223-7. PubMed ID: 10518614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine inhibits iron-uptake stimulated osteoclast differentiation by suppressing electron transport chain and MAPKs signaling.
    Zhang J; Hu W; Ding C; Yao G; Zhao H; Wu S
    Toxicol Lett; 2019 Oct; 313():50-59. PubMed ID: 31238089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel iron chelator that does not induce HIF-1 activity.
    Creighton-Gutteridge M; Tyrrell RM
    Free Radic Biol Med; 2002 Aug; 33(3):356-63. PubMed ID: 12126757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.
    Ma S; Henson ES; Chen Y; Gibson SB
    Cell Death Dis; 2016 Jul; 7(7):e2307. PubMed ID: 27441659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen regulation of gene expression: a study in opposites.
    D'Angio CT; Finkelstein JN
    Mol Genet Metab; 2000; 71(1-2):371-80. PubMed ID: 11001829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
    Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
    Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes.
    Michiels C; Minet E; Mottet D; Raes M
    Free Radic Biol Med; 2002 Nov; 33(9):1231-42. PubMed ID: 12398931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats.
    Ishizaka N; Saito K; Mori I; Matsuzaki G; Ohno M; Nagai R
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2282-8. PubMed ID: 16100038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiling identifies altered intracellular labile iron homeostasis as a contributing factor to the toxicity of adaphostin: decreased vascular endothelial growth factor secretion is independent of hypoxia-inducible factor-1 regulation.
    Hose C; Kaur G; Sausville EA; Monks A
    Clin Cancer Res; 2005 Sep; 11(17):6370-81. PubMed ID: 16144942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes.
    Göpfert T; Gess B; Eckardt KU; Kurtz A
    J Cell Physiol; 1996 Aug; 168(2):354-61. PubMed ID: 8707871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines.
    Furukawa T; Adachi Y; Fujisawa J; Kambe T; Yamaguchi-Iwai Y; Sasaki R; Kuwahara J; Ikehara S; Tokunaga R; Taketani S
    Oncogene; 2001 Aug; 20(34):4718-27. PubMed ID: 11498794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells.
    Koo SW; Casper KA; Otto KB; Gira AK; Swerlick RA
    J Invest Dermatol; 2003 May; 120(5):871-9. PubMed ID: 12713595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway.
    Shendge AK; Basu T; Panja S; Chaudhuri D; Mandal N
    Biomed Pharmacother; 2018 Oct; 106():454-465. PubMed ID: 29990833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and iron homeostasis: mechanistic and health aspects.
    Galaris D; Pantopoulos K
    Crit Rev Clin Lab Sci; 2008; 45(1):1-23. PubMed ID: 18293179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inducible factor-1α mediates iron uptake which induces inflammatory response in amoeboid microglial cells in developing periventricular white matter through MAP kinase pathway.
    Rathnasamy G; Ling EA; Kaur C
    Neuropharmacology; 2014 Feb; 77():428-40. PubMed ID: 24184387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
    Xu X; Sutak R; Richardson DR
    Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of hypoxia-inducible Factor-1 and iron regulatory protein 1 in iron uptake induced by acute hypoxia.
    Yang L; Wang D; Wang XT; Lu YP; Zhu L
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):128-135. PubMed ID: 30415773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of iron in cell cycle progression and the proliferation of neoplastic cells.
    Le NT; Richardson DR
    Biochim Biophys Acta; 2002 Oct; 1603(1):31-46. PubMed ID: 12242109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.